Serum level of soluble vascular cell adhesion molecule 1 is a valuable prognostic marker in colorectal carcinoma

Diseases of the Colon and Rectum

Volumn 52, Issue 7, 2009, Pages 1330-1336

  Okugawa, Yoshinaga ^a   Miki, Chikao ^a   Toiyama, Yuji ^a   Koike, Yuhki ^a   Inoue, Yasuhiro ^a   Kusunoki, Masato ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cancer tissue; Colorectal cancer; Serum; Soluble vascular cell adhesion molecule 1; Vascular cell adhesion molecule 1

Indexed keywords

VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER RISK; CANCER SURVIVAL; CANCER TISSUE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DISTANT METASTASIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PARAMETER; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TUMOR VOLUME; BLOOD; CANCER STAGING; CASE CONTROL STUDY; COHORT ANALYSIS; COLON TUMOR; DISEASE FREE SURVIVAL; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; RECTUM TUMOR; RISK FACTOR; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COHORT STUDIES; COLONIC NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RECTAL NEOPLASMS; RISK FACTORS; SEX FACTORS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 67650721787     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/DCR.0b013e3181a0d144     Document Type: Article

References (29)

1. Garcia M, Jemal A, Ward EM, et al. Global cancer facts & figures 2007. Atlanta, GA: American Cancer Society, 2007.
2. Heller DG. An overview of adjuvant therapy for colorectal cancer. Eur J Cancer 1995;31A:1255-1263
3. Fidler IJ. Critical determinants of metastasis. Semin Cancer Biol 2002;12:89-96.
4. Chan DA, Giaccia AJ. Hypoxia, gene expression, and metastasis. Cancer Metastasis Rev 2007;26:333-339
5. ten Kate M, Hofland LJ, van Grevenstein WM, van Koetsveld PV, Jeekel J, van Eijck CH. Influence of proinflammatory cytokines on the adhesion of human colon carcinoma cells to lung microvascular endothelium. Int J Cancer 2004;112:943-950
6. Basoglu M, Yildirgan MI, Taysi S, et al. Levels of soluble intercellular adhesion molecule-1 and total sialic acid in serum of patients with colorectal cancer. J Surg Oncol 2003;83:180-184 (Pubitemid 36807949)
7. Alexiou D, Karayiannakis AJ, Syrigos KN, et al. Clinical significance of serum levels of E-selectin, intracellular adhesion molecule- 1, and vascular cell adhesion molecule-1 in gastric cancer patients. Am J Gastroenterol 2003;98:478-485 (Pubitemid 36232403)
8. Shin J, Kim J, Ryu B, Chi SG, Park H. Caveolin-1 associated with VCAM-1 dependent adhesion of gastric cancer cells to endothelial cells. Cell Physiol Biochem 2006;17:211-220 (Pubitemid 43946277)
9. Higashiyama A, Watanabe H, Okumura K, Yagita H. Involvement of tumor necrosis factor alpha and very late activation antigen 4/vascular cell adhesion molecule 1 interaction in surgical- stress-enhanced experimental metastasis. Cancer Immunol Immunother 1996;42:231-236 (Pubitemid 26183206)
10. Ding YB, Chen GY, Xia JG, Zang XW, Yang HY, Yang L. Association of VCAM-1 overexpression with oncogenesis, tumor angiogenesis and metastasis of gastric carcinoma. World J Gastroenterol 2003;9:1409-1414 (Pubitemid 36992323)
11. Kobayashi H, Boelte KC, Lin PC. Endothelial cell adhesion molecules and cancer progression. Curr Med Chem 2007;14:377-386 (Pubitemid 46299685)
12. Wu TC. The role of vascular cell adhesion molecule-1 in tumor immune evasion. Cancer Res 2007;67:6003-6006 (Pubitemid 47037476)
13. Manevich E, Grabovsky V, Feigelson SW, Alon R. Talin 1 and paxillin facilitate distinct steps in rapid VLA-4-mediated adhesion strengthening to vascular cell adhesion molecule 1. J Biol Chem 2007;282:25338-25348 (Pubitemid 47372824)
14. Klemke M, Weschenfelder T, Konstandin MH, Samstag Y. High affinity interaction of integrin α4β1 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) enhances migration of human melanoma cells across activated endothelial cell layers. J Cell Physiol 2007;212:368-374 (Pubitemid 47025626)
15. DiVietro JA, Brown DC, Sklar LA, Larson RS, Lawrence MB. Immobilized stromal cell-derived factor-1α triggers rapid VLA-4 affinity increases to stabilize lymphocyte tethers on VCAM-1 and subsequently initiate firm adhesion. J Immunol 2007;178:3903-3911
16. Chigaev A, Waller A, Zwartz GJ, Buranda T, Sklar LA. Regulation of cell adhesion by affinity and conformational unbending of α4β1 integrin. J Immunol 2007;178:6828-6839 (Pubitemid 46847408)
17. Gearing AJ, Hemingway I, Pigott R, Hughes J, Rees AJ, Cashman SJ. Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: pathological significance. Ann NY Acad Sci 1992;667:324-331 (Pubitemid 23061599)
18. Alexiou D, Karayiannakis AJ, Syrigos KN, et al. Serum levels of E-selectin, ICAM-1, and VCAM-1 in colorectal cancer patients: correlations with clinicopathological features, patient survival and tumor surgery. Eur J Cancer 2001;37:2392-2397 (Pubitemid 33097476)
19. Coskun U, Sancak B, Sen I, et al. Serum P-selectin, soluble vascular cell adhesion molecule-I (s-VCAM-I) and soluble intercellular adhesion molecule-I (s-ICAM-I) levels in bladder carcinoma patients with different stages. Int Immunopharmacol 2006;6:672-677 (Pubitemid 43295472)
20. De Cicco C, Ravasi L, Zorzino L, et al. Circulating levels of VCAM and MMP-2 may help identify patients with more aggressive prostate cancer. Curr Cancer Drug Targets 2008;8: 199-206. (Pubitemid 351666856)
21. Christiansen I, Sundstrom C, Totterman TH. Elevated serum levels of soluble vascular cell adhesion molecule-1 (sVCAM-1) closely reflect tumour burden in chronic B-lymphocytic leukemia. Br J Haematol 1998;103:1129-1137 (Pubitemid 29012655)
22. Kamezaki S, Kurozawa Y, Iwai N, Hosoda T, Okamoto M, Nose T. Serum levels of soluble ICAM-1 and VCAM-1 predict preclinical cancer. Eur J Cancer 2005;41:2355-2359 (Pubitemid 41415613)
23. Astler VB, Coller FA. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 1954; 139:846-852
24. Mulcahy HE, Duffy MJ, Gibbons D, et al. Urokinase-type plasminogen activator and outcome in Dukes' B colorectal cancer. Lancet 1994;344:583-584 (Pubitemid 24267218)
25. Kay EW, Mulcahy H, Walsh CB, Leader M, O'Donoghue D. Cytoplasmic c-erbB-2 protein expression correlates with survival in Duke's B colorectal carcinoma. Histopathology 1994;25: 455-461 (Pubitemid 24356788)
26. Takahashi Y, Tucker SL, Kitadai Y, et al. Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer. Arch Surg 1997;132:541-546 (Pubitemid 27215097)
27. Dorudi S, Hanby AM, Poulsom R, Northover J, Hart IR. Level of expression of E-cadherin mRNA in colorectal cancer correlates with clinical outcome. Br J Cancer 1995;71:614-616
28. Toiyama Y, Miki C, Inoue Y, et al. Soluble intercellular adhesion molecule-1 as a prognostic marker for stage II colorectal cancer patients. Ann Surg Oncol 2008;15:1617-1624
29. Pigott R, Dillon LP, Hemingway IH, Gearing AJ. Soluble forms of E-selectin, ICAM-1, and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun 1992;187:584-589